RT Journal Article
SR Electronic
T1 SARS-CoV-2: Viral Mechanisms and Possible Therapeutic Targets — What to Learn from Rheumatologists
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP jrheum.200657
DO 10.3899/jrheum.200657
A1 Carlos Antonio  Moura
A1 Carlos Geraldo  Moura
A1 Ana Luísa  Cerqueira De Sant’ana Costa
YR 2020
UL http://www.jrheum.org/content/early/2020/07/09/jrheum.200657.abstract
AB It was with great interest that we read the editorial by Drs. Cron and Chatham1 linking the cytokine storm syndrome (CSS) seen in macrophage activation syndrome, common in the rheumatological setting, with a CSS postulated to be a background in the novel coronavirus (SARS-CoV-2) infection. Amid the high contagion of the virus, science was also infected by an infodemic, compelled to finish the race to find effective therapies, while physicians managed real-world patients.